The drug demonstrated partial reversal of cognitive deficits by restoring the brain's own 'self-cleanup' process.
Scientists have identified a potential new target for treating Alzheimer's disease that works by restoring the brain's own 'self-cleanup' process.The target is already used in preexisting Parkinson's drugs and demonstrated partial reversal of cognitive deficits in aged study mice.Alzheimer's affects roughly 5.8 million Americans, according to the Centers for Disease Control and Prevention.
You might have heard dopamine being referred to as the 'pleasure hormone' due to its role in the brain's reward center. But the neurotransmitter has many other roles in our brains too. 'Dopamine regulates emotion, movement, and motivation,' Watamura said.And, according to these findings, dopamine may also play a role in staving off cognitive decline.
Indonesia Berita Terbaru, Indonesia Berita utama
Similar News:Anda juga dapat membaca berita serupa dengan ini yang kami kumpulkan dari sumber berita lain.
Alzheimer's Breakthrough As Drug Fights Damage in Late-Onset DiseaseScientists have turned patient skin cells into brain neurons, revealing key Alzheimer's insights.
Baca lebih lajut »
Cat poo parasites could cure deadly disorders like Alzheimer’s, Parkinson’sA new study reveals that an engineered strain of Toxoplasma gondii could help formulate new treatments for neurodegenerative disorders.
Baca lebih lajut »
How to lower your Alzheimer's, Parkinson's risk when you hit the gymA recent study has shown that belly size is directly linked to brain dysfunction and can be an early indication of dementia. The study, carried out by the Washington University School of Medicine, was published as a pilot study in the Journal of Aging and Disease.
Baca lebih lajut »
Alzheimer's Breakthrough As Nasal Spray May Boost MemoryA new nasally-administered antibody therapy could present a new way forward in treating degenerative brain conditions.
Baca lebih lajut »
Alzheimer’s Imaging Breakthrough: Fluorescent Sensors Penetrate Blood-Brain BarrierScience, Space and Technology News 2024
Baca lebih lajut »
European drug regulator rejects Alzheimer's treatment Leqembi from Biogen, EisaiThe committee said Leqembi’s effect on delaying cognitive decline does not outweigh “the risk of serious side effects associated with the…
Baca lebih lajut »